Source record
A weekly glucose-pattern note for the diabetes visit
Dieser Text steht auf Englisch, bis eine Übersetzung vorliegt.
This source is an illustrative composite written by Madical AI Use on 14 September 2026. It is not a glucose-outcome study and it quotes no time-in-range result, hypoglycemia rate, or insulin-dose change. It describes a clinician-edited summary of a continuous-glucose export. The ADA Standards of Care are cited only because they already discuss glucose-monitoring metrics. FDA’s artificial-pancreas materials are cited to mark closed-loop systems as a separate regulated class.
- Source date
- 14. Sept. 2026 · Jahr 2026
- Evidence label
- Illustrativ
- Source type
- Krankenhaus
Citation
Illustrative composite, Madical AI Use
Madical AI Use. Illustrative composite: a weekly glucose-pattern note for the diabetes visit. Index entry dated 14 September 2026. Not a peer-reviewed paper or a device study.
Key public facts
- The draft is built from a continuous-glucose export the clinic already receives.
- The note may mention time in range, overnight lows, and days that look different. Those phrases describe the file. They are not measured outcomes of this composite.
- The clinician edits the draft and decides any insulin change.
- Autonomous dosing is excluded.
- Closed-loop insulin systems are separate regulated devices and are not this workflow.
References used to construct the scenario
- American Diabetes Association. Standards of Care in Diabetes. Cited for the existence of public glucose-monitoring guidance, not as a result of this composite.
- U.S. Food and Drug Administration. Artificial pancreas device systems. Cited to mark automated insulin delivery as a separate regulated class.
Eintrag für Bildung und Marktüberblick. Kein Rat und keine Empfehlung.